BIOS Equity Partners III, LP
SEC CIK 1831976 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACTU | ACTUATE THERAPEUTICS, INC. | Dir, 10% | 573.4K | $4.00M | $225.0K | 4 | 2024-08-14 | 2024-08-14 |
Most active insiders at ACTU, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | THOMSON TODD S | Dir, 10% | — | $1.62M |
| 2 | SCHMITT DANIEL M | Pres, CEO, Dir | — | — |
BIOS Equity Partners III, LP made no open-market trades at ACTU in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BIOS Equity Partners III, LP | Dir, 10% | C - Cnv Deriv | — | +9.38M | 573.4K | New | — |
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BIOS Equity Partners III, LP | Dir, 10% | S - Sale+OE | $9.00 | -25.0K | 980.4K | -2% | -$225.0K |
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BIOS Equity Partners III, LP | Dir, 10% | P - Purchase | $8.00 | +500.0K | 1.26M | +66% | +$4.00M |
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BIOS Equity Partners III, LP | Dir, 10% | X - OptEx | $5.27 | +38.0K | 133.6K | +40% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations